Company CytRx Corporation Nasdaq
Equities
US2328286081
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 10/22/10 |
John Caloz
DFI | Director of Finance/CFO | 72 | 01/07/01 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Felix Kratz
PRN | Corporate Officer/Principal | - | 17/14/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 29/21/29 |
Cary Claiborne
BRD | Director/Board Member | 64 | 27/22/27 |
Joel Caldwell
BRD | Director/Board Member | 69 | 12/17/12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 495,092 | 492,306 ( 99.44 %) | 0 | 99.44 % |
Company contact information
LadRx Corp.
11726 San Vicente Boulevard Suite 650
90049, Los Angeles
+310 826 5648
http://www.ladrxcorp.comSector
1st Jan change | Capi. | |
---|---|---|
+33.03% | 49.46B | |
+1.41% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.70% | 26.61B | |
-22.68% | 18.64B | |
+8.35% | 13.16B | |
+29.30% | 12.55B | |
+24.30% | 12.1B |